Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Abrdn Physical Platinum Shares ETF (PPLT) vs Royalty Pharma plc Class A Ordinary Shares (RPRX) Price & Performance

Abrdn Physical Platinum Shares ETFTrade
Royalty Pharma plc Class A Ordinary SharesTrade

Price performance (Past 24H)

Key statistics

Abrdn Physical Platinum Shares ETF vs Royalty Pharma plc Class A Ordinary Shares — how do they compare? Abrdn Physical Platinum Shares ETF trades at $15.33 (market cap $1.93B), while Royalty Pharma plc Class A Ordinary Shares trades at $56.2 (market cap $25.27B). The key difference: Royalty Pharma plc Class A Ordinary Shares is far larger — about 13.1× Abrdn Physical Platinum Shares ETF's market cap, and Royalty Pharma plc Class A Ordinary Shares pays a 1.66% dividend while Abrdn Physical Platinum Shares ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Abrdn Physical Platinum Shares ETF for 42 Days and Royalty Pharma plc Class A Ordinary Shares for 0 Days on average.

PPLTRPRX
Market Cap
$1.93B$25.27B
Volume
2,947,5563,671,183
Sector
Commodities - Metals/AgricultureHealth
52-Week High
$25.23$63.96
52-Week Low
$13.73$35.44
Typical Hold Time
42 Days0 Days
Enterprise Value
—$32.50B
Dividend Yield
—1.66%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Abrdn Physical Platinum Shares ETF

PPLT, the abrdn Physical Platinum Shares ETF, is trading at $14.78, down 4.46% with a bearish technical outlook. Moving averages and oscillators signal selling pressure, though RSI levels suggest potential oversold conditions. Recent news highlights platinum's underperformance in the precious metals rally, with technical and fundamental signals pointing to continued weakness despite historical seasonal patterns.

The outlook remains cautious with bearish momentum dominating. Investment opportunity exists for contrarian investors betting on a catch-up trade in platinum, but risks include sustained supply contango and weak relative performance versus gold and silver. Key catalysts would be renewed industrial demand or shifts in precious metals sentiment.

Royalty Pharma plc Class A Ordinary Shares

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

PPLT
100% Buy0% Sell
Avg holding period · 42 Days
RPRX
100% Buy0% Sell
Avg holding period · 0 Days

About Abrdn Physical Platinum Shares ETF

PPLT is a physically-backed ETF designed to track the spot price of platinum, less the Trust's expenses. It holds physical platinum bullion in secure vaults, providing investors with a liquid and cost-effective way to access the platinum market without the logistical challenges of direct ownership.

Read more on PPLT →

About Royalty Pharma plc Class A Ordinary Shares

Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.

Read more on RPRX →